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Background: Cardiac dysfunction is the major cause of morbidity and mortality in diabetes.
Myocardial Performance Index (MPI/Tei Index) includes both systolic and diastolic time
intervals to assess the global cardiac dysfunction. Our aim was to assess the MPI in patients
with type 2 diabetes.
Material and methods: This hospital-based analytic observational study was performed in the
tertiary care center. The conventional Doppler parameters, tissue Doppler-derived E/E0 and
MPI, were measured in all patients.
Results: 100 patients with type 2 diabetes were included in the study. 65 patients showed
diastolic dysfunction, 33 with Grade I diastolic dysfunction, 23 with Grade II diastolic
dysfunction, and 14 patients with Grade III diastolic dysfunction. The conventional Doppler
showed abnormality in 44% of patients (33 patients with Grade I and 14 patient with Grade
III). 23 patients were in Grade II diastolic dysfunction (12 patients showed reversal E/A on
valsalva maneuver and 11 patients showed abnormality in tissue Doppler-derived E/E0, E/
E0 > 15). MPI with cut-off 0.36 was found to have 94% sensitivity, 100 speciﬁcity, and 94% PPV
for the detection of cardiac dysfunction. MPI negatively correlated with systolic dysfunction
(rho = 0.455, p < 0.001) and positively correlated with grade of diastolic dysfunction
(rho = 0.832, p < 0.001) and NYHA grading of dyspnea (rho = 0.872, p < 0.001)
Conclusions: MPI as a single parameter can be used for assessment in diabetic cardiac
dysfunction.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Cardiac dysfunction is the major cause of morbidity and
mortality in diabetes.1 Most commonly the cardiac dysfunc-
tion in diabetes is caused by the coronary atherosclerosis.* Corresponding author.
E-mail address: manjunath.r.goroshi@gmail.com (M. Goroshi).
http://dx.doi.org/10.1016/j.ihj.2015.06.022
0019-4832/# 2015 Cardiological Society of India. Published by ElsevierBut the epidemiological and clinical data show that diabetes
mellitus independently increases the risk for cardiac dysfunc-
tion and heart failure.2–5 Diabetic cardiomyopathy was ﬁrst
reported in 1972 by Rubler.4 It is characterized by the
development of diastolic dysfunction at the early stage, B.V. All rights reserved.
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artery disease, hypertension, or signiﬁcant valvular heart
disease.
Cardiac dysfunction in diabetes can manifest as both
systolic as well as diastolic dysfunction, and routinely ejection
fraction and conventional Doppler parameters are used for its
evaluation. Ejection fraction is a less sensitive parameter in
early systolic dysfunction and cannot be used routinely in
asymptomatic patients.6 The sensitivity for the detection of
diastolic dysfunction by conventional Doppler parameters is
decreased by pseudonormalization pattern in Grade II diastol-
ic dysfunction. This calls for the use of tissue Doppler-derived
indices, i.e., E/E0 for differentiation.
Myocardial Performance Index (MPI/Tei Index), which
includes both systolic and diastolic time intervals to assess
the global cardiac dysfunction was used by Tei and his co-
workers in 1995.7 Tei Index uses the measurement possible on
ﬂow wave Doppler and is as sensitive as the tissue Doppler
measurements. The index is mainly used in amyloidosis,
dilated cardiomyopathy, ischemic heart disease, and conges-
tive heart failure.
Our aim was to assess the MPI in patients with type 2
diabetes without hypertension, regional wall motion abnor-
mality, chronic alcoholism, and valvular heart disease.
2. Material and methods
This hospital-based analytic observational study was per-
formed in the tertiary care center. Patients with type 2 diabetes
were screened for inclusion. All the subjects were interviewed,
examined, and investigated as per the predesigned proforma,
and the study was approved by the institutional ethics
committee. Fasting lipid proﬁle, blood urea and serum
creatinine, fasting and post-meal blood sugar, and 12-lead
ECG were done in all study subjects.
2.1. Echocardiographic protocol
Their echocardiographic indices were evaluated serially using
PHILLIPS HD11XE with frequency of 4.2 MHz.
2.1.1. Transmitral ﬂow Doppler measurement
For recordings of the mitral inﬂow velocity pattern, the sample
volume of the pulsed Doppler was placed between the tips of
the mitral leaﬂets in the apical four-chamber view. From theFig. 1 – (A and B) Measurement of MPI and is calculatransmitral recordings, the following measurements were
carried out: peak E velocity in meters per second (peak early
transmitral ﬁlling velocity during early diastole), peak A
velocity in meters per second (peak transmitral atrial ﬁlling
velocity during late diastole), and deceleration time in
milliseconds (time elapsed between peak E velocity and the
point where the extrapolation of the deceleration slope of the E
velocity crosses the zero baseline). The deﬁnitions published
by the Canadian consensus on diastolic dysfunction by
echocardiography were used to classify diastolic function as
follows: normal, impaired relaxation, pseudonormal, and
restrictive pattern.8 To distinguish subjects with normal
diastolic function from those with a pseudonormalized
pattern of ventricular ﬁlling TDI derived E/E0 >15 and valsalva
maneuver were used.
2.1.2. Tissue Doppler measurement
TDI of the mitral annulus was obtained from the apical four-
chamber view. A 1.5-mm sample volume was placed sequen-
tially at the medial mitral annulus. Early diastolic velocity E0
was measured and E/E0 was calculated (Fig. 1).
2.1.3. MPI measurement
Doppler time intervals were measured from mitral inﬂow and
left ventricular outﬂow Doppler tracings, as described by Tei
and co-workers7. The interval 'a' from cessation to onset of
mitral inﬂow is equal to the sum of isovolumic contraction
time (ICT), ejection time (ET), and isovolumic relaxation time
(IRT). ET 'b' is derived from the duration of the left ventricular
outﬂow Doppler velocity proﬁle. The sum of ICT and IRT was
obtained by subtracting b from a. The MPI was calculated as
shown in Fig. 1: (a  b)/b.
2.2. Statistical analysis
All demographic, echo parameters were presented as mean
 SD. Categorical variables were expressed in actual number
and percentage. Age, duration of diabetes, and all echo
parameters were compared between different groups by
performing unpaired t-test for normalized data; Mann–
Whitney test was performed for non-normalized data.
Categorical variables were compared by chi-square test.
Receiver operating characteristic (ROC) curve was used to
derive cut-off value for the MPI to detect cardiac dysfunction.
All the tests were two sided; p-value < 0.05 was considered as
statistically signiﬁcant. Pearson correlation test was used toted by (a S b)/b and (C) tissue Doppler-derived E0.
Table 1 – Baseline characteristics of patients (n = 100).
Age (yrs) 53.28  8.8
Gender (F/M) 62/38
Duration diabetes (yrs) 5.01  3.4
BMI 26.4  2.13
SBP 116.2  14.5
DBP 82.1  8.6
Fasting blood sugars 119.93  22.86
HbA1c 7.8  1.6
T. Triglyceride 134  24.8
T. Cholesterol 177.6  16.2
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rameters and NYHA class of breathlessness. Statistical
software SPSS version 20 was used for statistical analysis.
3. Results
A total of 145 patients were screened for inclusion; of that, 30
patients with hypertension, 2 with valvular lesion, and 3
patients with chronic alcoholism were excluded. 110 patients
underwent echocardiographic evaluation; 10 patients were
excluded from the study because of regional wall motion
abnormality. Baseline characteristics of 100 patients with
diabetes are shown in Table 1.
70% of the patients were found to have diastolic dysfunc-
tion; 25% of the patients were found to have reduced systolic
function in the form of ejection fraction less than 50%.
Depending on diastolic dysfunction, patients were divided
into four groups:
Group A with no diastolic dysfunction (n = 30),
Group B with Grade I diastolic dysfunction (n = 33),
Group C with Grade II diastolic dysfunction (n = 23)
Group D with Grade III diastolic dysfunction (n = 14).
Comparison of different echocardiographic parameters is
shown in Table 2. On ROC curve analysis (Fig. 2), MPI showed
area under curve as 0.948, with cut-off 0.36, and was found to
have 94% sensitivity, 100 speciﬁcity, and 94% PPV for the
detection of cardiac dysfunction. MPI negatively correlated
with systolic dysfunction (rho = 0.455, p < 0.001) and positively
correlated with grade of diastolic dysfunction (rho = 0.832,
p < 0.001) and NYHA grading of dyspnea (rho = 0.872, p < 0.001)
4. Discussion
The MPI is an easily performable, recordable and reproducible
parameter by ﬂow Doppler. The standardization of MPI is not
required as number of studies have documented that the MPI
is independent of arterial pressure, heart rate, ventricular
geometry, atrioventricular valve regurgitation, afterload, andTable 2 – Comparison of echocardiographic parameters betwee
Group A
(n = 30)
Group B
(n = 33)
Group C
(n = 23)
Age (yrs) 48.4  11.08 51.96  6.67 58.13  6.66
Duration of DM (yrs) 5  1.5 5.31  2.38 7.86  3.26
LA (mm) 28.4  1.6 34.69  3.10 36.13  4.59
EF (%) 58.8  1.64 64.2  11.7 53.69  15.3
E (m/s) 0.92  0.11 0.72  0.17 0.93  0.19
A (m/s) 0.74  0.06 0.90  0.17 0.76  0.17
E/A 1.22  0.57 0.81  0.16 1.23  0.15
DT (ms) 210  36.5 222  49 190  40 
a 0.372  0.048 0.375  0.046 0.399  0.07
b (ET) 0.3  0.046 0.259  0.035 0.244  0.05
MPI 0.24  0.23 0.45  0.130 0.6  0.11
E/E0 9.49  6.42 11.81  3.9 16.39  2.69preload in patients who are in a supine position.7,9–12 We
compared the index with conventional Doppler-derived
parameters.
4.1. Conventional Doppler parameters in diabetes
The conventional Doppler showed abnormality in 44% of
patients (33 patients with Grade I and 14 patient with Grade III).
23 patients were in Grade II diastolic dysfunction (12 patients
showed reversal E/A on valsalva maneuver and 11 additional
patients showed abnormality in tissue Doppler-derived E/E0, E/
E0 > 15).
The incidence of diastolic dysfunction in patients with type
2 DM on conventional Doppler parameters was comparable to
other studies.13,14 The tissue Doppler-derived E/E0 has addi-
tionally detected dysfunction in 11% of the patients, which
increased diastolic dysfunction to 70%, which was comparable
to the study by Boyer et al.15 Boyer et al. had used the tissue
Doppler in addition to the valsalva maneuver to identify the
cardiac dysfunction. For the detection of cardiac dysfunction,
relying on a single parameter is not possible. In our study, in
contrast to Boyers et al., the reliability of MPI alone for
detection of cardiac dysfunction was equal to that of
combining TDI and conventional Doppler parameters.
4.2. MPI in diabetes
LV systolic as well as diastolic dysfunction induces impaired
relaxation (prolongation of IRT). The fact that both phases of
LV function are simultaneously reﬂected in the diastolicn groups.
Group D
(n = 14)
Group
A vs. B
p valve
Group
A vs. C
p value
Group
A vs. D
p value
 58.85  6.90 0.1, NS <0.001, HS <0.001, HS
 7.07  3.02 <0.001, HS <0.001, HS <0.001, HS
 39.78  2.99 <0.001, HS <0.001, HS <0.001, HS
8 37.28  11.96 0.016, S 0.076, S <0.001, HS
 1.05  0.24 <0.001, HS 0.6, NS 0.012, S
 0.55  0.21 <0.001, HS 0.569, NS <0.001, HS
 2.09  0.74 <0.001, HS 0.699, NS <0.001, HS
150  19 <0.125, NS 0.125, NS <0.001, HS
5 0.436  0.09
8 0.25  0.059
9 0.680  0.2 <0.001, HS <0.001, HS <0.001, HS
 21.75  8.58 <0.001, HS <0.001, HS <0.001, HS
Fig. 2 – Receiver operating characteristic curve for MPI to
detect cardiac dysfunction, AUC = 0.948.
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identiﬁcation of impaired relaxation.16,17 Thus, MPI has a close
correlation with diastolic hemodynamic indices of relaxation
and appears superior to conventional diastolic parameters in
the detection of impaired relaxation. MPI in our study group
was signiﬁcantly elevated in all grades of diastolic dysfunc-
tion. In patients with pseudonormalization of diastolic
dysfunction, prolongation of MPI can be explained by the
shortening of ET as compared to normal group (Table 2). MPI in
our study effectively differentiated the pseudonormalization
from normal and it prolonged as degree of diastolic dysfunc-
tion increases.
4.3. Pseudonormalization of MPI
A debate exists regarding the ability of the index to reﬂect the
severity of LV diastolic dysfunction in more advanced stages of
diastolic dysfunction (pseudonormalization or restrictive
physiology), especially in cases with preserved systolic
function.18,19 In our study, Grade III diastolic dysfunction
(restrictive physiology) showed prolongation of MPI; this can
be explained by the fact that in most of the patients in Grade III
diastolic dysfunction, patients were associated with severe
systolic dysfunction (EF = 37.28  11.96%). When severe sys-
tolic dysfunction exists, a signiﬁcant increment (worsening) of
the quotient ICT/ET (due to prolongation of ICT and shortening
of ET) is induced, which not only counterbalances the short
IRT, but also increases the index value.
4.4. MPI and systolic dysfunction
Because of the potent systolic parameters that contribute to the
MPI, such as ICT and ET, the index detects with reliability
current alterations of LV systolic function. Index in our studyshowed a strong inverse relation with ejection fraction, the
higher the value of the index, the lower the ejection fraction, and
vice versa. The results were comparable to other studies.12–16
5. Conclusions
MPI as a single parameter can be used for assessment in
diabetic cardiac dysfunction.
6. Limitations of the study
Sample size was a major limitation in our study. We have not
included normal subjects as control group, but with that
limitation also, the index was able to differentiate the
abnormal cardiac dysfunction with good sensitivity and
speciﬁcity.
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